CITI Good Clinical Practice (GCP) Practice Exam

These questions are part of the practice quiz. Start practicing

• Which type of device is required to have an IDE before clinical trials can begin?
• What is the definition of a clinical trial?
• What does the term "Device" refer to in the context of clinical research?
• What should an investigator do if a new beneficial drug becomes available during a clinical study?
• What is a Letters of Cross-Reference used for in clinical trials?
• What must the consent form include regarding access to medical records?
• Why is it essential to document training for all trial personnel?
• What information is typically included in a Clinical Study Report (CSR)?
• What is an essential requirement for proper participant recruitment in clinical trials?
• Why is the Institutional Review Board (IRB) essential in clinical trials?
• What purpose do written Standard Operating Procedures (SOPs) serve?
• Which type of device study is characterized by minimal risk to patients?
• What does 21 CFR 56 relate to?
• What financial information must investigators report under 21 CFR 54?
• Who can the investigator delegate responsibilities for product accountability to?
• What is an Investigational New Drug Application (IND)?
• Which scenario requires the submission of an SAE report?
• What does Form FDA 1571 represent?
• What does an Investigator's Brochure contain?
• What is a primary reason for adhering to inclusion and exclusion criteria in trials?
• What type of information should be included in a clinical trial protocol?
• In the context of clinical trials, what does "protocol adherence" refer to?
• What is a key consideration for maintaining informed consent during a clinical trial?
• What must be verified about the regulations when obtaining informed consent?
• At which stage are regulatory documents generated for a site?
• What is the significance of clinical trial registration?
• What should an investigator do upon learning that a subject has been in a car crash resulting in injury?
• During an FDA inspection, what will the inspectors primarily review?
• What is the significance of inclusion and exclusion criteria in clinical studies?
• What is the role of the Case Report Form in clinical trials?
• What is a key consideration when obtaining consent from subjects for clinical trials?
• What defines a Humanitarian Use Device (HUD)?
• What is the significance of blinding in clinical trials?
• What does the term "informed consent document" refer to?
• What is an investigator's responsibility according to GCP?
• What does "blinding" refer to in clinical trials?
• What does "data integrity" refer to in clinical research?
• What role does the Institutional Review Board (IRB) play in clinical trials?
• What is a serious adverse event (SAE)?
• What is the role of a Clinical Research Associate (CRA)?
• What does a report of an unexpected adverse event indicate to the sponsor?
• How should investigators manage protocol amendments?
• How often must the IRB review ongoing clinical trials?
• Which of the following is essential to the validity of clinical trial results?
• How can trial sponsors ensure participant recruitment is ethical?
• What criteria classify an event as "unexpected" in the context of serious adverse events?
• Why is compliance with regulatory requirements important in GCP?
• What is meant by “risk assessment” in GCP?
• How does trial monitoring relate to GCP compliance?
• Who is responsible for determining the causality of a serious adverse event in a clinical trial?
• Which document outlines broader confidentiality requirements related to medical records than those required by the FDA or HHS?
• How is a placebo used in clinical trials?
• What should an investigator do regarding informed consent?
• What is the primary purpose of a Humanitarian Device Exemption (HDE)?
• What role does the sponsor play in a clinical trial?
• What is OHRP primarily concerned with?
• What is the significance of a Data and Safety Monitoring Board (DSMB)?
• What is the main responsibility of the investigator in relation to an investigational product?
• When must the consent for participation in clinical trials be obtained?
• What is essential for obtaining informed consent from participants?
• What does the term “subject safety” encompass in clinical trials?
• What does the consent form need to state regarding the number of subjects in a study?
• What is the purpose of randomization in clinical trials?
• Which statement accurately describes an Investigational Drug?
• What kind of products does the term “Biologics” encompass?
• How is an "inspection" defined according to ICH E6?
• What type of costs should be outlined in the consent form for subjects?
• What does the term “informed consent” mean in clinical research?
• What is the purpose of Form FDA 1572, Statement of Investigator?
• What defines a non-compliance issue in clinical trials?
• Which statement best describes the role of the IRB in emergency situations involving informed consent?
• To whom must an investigator report all adverse events during a clinical trial?
• Why is the documentation of informed consent critical?
• Why is it essential for informed consent forms to include participant withdrawal rights?
• What must be included in the consent forms regarding the probability of assignment to trial arms?
• Which of the following is NOT a benefit of effective monitoring in clinical trials?
• Which document is critical for the sponsor-investigator relationship?
• In which scenario is an explanation required in the consent form for research involving more than minimal risk?
• When must investigators inform subjects about significant new findings during a study?
• What is the importance of an independent monitor in a clinical trial?
• How are evaluations of Unanticipated Adverse Device Effects transmitted to the FDA?
• Which monitoring visit would not include an inventory of investigational agents?
• What is an Investigational Product?
• What is the purpose of a prestudy visit?
• What must researchers ensure before starting a clinical trial?
• What is the purpose of a protocol in clinical trials?
• Which of the following is NOT considered a serious adverse event?
• What is an investigator primarily responsible for protecting during a study?
• Which aspect is crucial in obtaining informed consent from participants?
• Why is data integrity critical in clinical trials?
• What is a key ethical consideration in clinical trials?
• Which of the following happens after an investigational study is terminated?
• When must a sponsor submit an IND Safety Report to the FDA?
• Where is information on the storage requirements for an investigational product typically found?
• Which factor may complicate the determination of an adverse event's causality?
• Why is accurate reporting of adverse events essential?
• How does GCP address participant safety in clinical trials?
• What is a protocol violation in clinical trials?
• What is the role of regulatory authorities in clinical trials?
• What type of adverse event requires additional medical intervention to prevent lasting impairment?
• How should the integrity of trial data be maintained?
• What is the importance of training for trial personnel in GCP?
• What constitutes exculpatory language in a consent form?
• What information related to subjects’ biospecimens must be included in the consent form?
• Who is responsible for reporting Unanticipated Adverse Device Effects to the FDA?
• What does the term "Biological Product" refer to?
• What is a key ethical consideration in clinical research?
• What is the primary purpose of Good Clinical Practice (GCP)?
• What is a critical component of the informed consent process?
• What does signing the Form FDA 1572 require from the investigator?
• Which organization developed the International Conference on Harmonisation (ICH) guidelines for GCP?
• At what visit should all unused investigational agents be returned to the sponsor?
• Which of the following is NOT a responsibility of the investigator?
• What component is crucial for drug accountability during clinical trials?
• Which document is not essential for participating in a clinical trial?
• What happens at the end of a study regarding investigational agents?
• Which condition would exempt a study from requiring an IND?
• Which activity would not typically be a focus during routine monitoring?
• What is the primary purpose of conducting a clinical trial?
• Which of the following outcomes categorizes an event as a Serious Adverse Event (SAE)?
• What key principles are outlined in the Declaration of Helsinki?
• What defines an Adverse Event (AE) in clinical investigations?
• What is the key role of an investigator in a clinical study?
• What type of device presents a potential for serious risk to the health or safety of subjects?
• What must be documented according to Good Clinical Practice (GCP)?
• What is the role of conflicts of interest management plans in clinical trials?
• What is required for a 510(k) Premarket Notification submission?
• What does the term "prospective study" imply in clinical research?
• What is a key outcome of disclosing conflicts of interest?
• Which of the following best defines an Investigational New Drug (IND)?
• Why is it important to maintain confidentiality of participant data?
• What critical information must be communicated to participants during the informed consent process?
• In a clinical study, an investigator finds a subject with elevated WBC counts but no symptoms. What should be done?
• What role do statistical methods play in clinical trial design?
• What is the role of the Investigator in a clinical trial under an IDE?
• Which of the following is NOT a requirement for informed consent?
• What constitutes a 'treatment group' in a clinical trial?
• Under which condition does the FDA permit verbal consent without a signature?
• What must be discussed with subjects regarding risks in the consent process?
• Why is it important for clinical trials to adhere to ethical guidelines?
• What type of language should be avoided in the consent form?
• What is included in the informed consent process?
• Who is responsible for the annual reporting of an IND to the FDA?
• How should recruitment for clinical trial participants be conducted?
• What does GCP require regarding the reporting of adverse events?
• According to ICH E6, how should risks be managed throughout the trial process?
• Which study visits review subjects' signed informed consent forms?
• In GCP, what is the primary reason for maintaining a clinical trial master file?
• In what setting do ethical review boards operate?
• Why should investigators report findings of adverse events promptly?
• What does a well-designed clinical trial aim to achieve?
• What is the overall goal of monitoring, audits, and inspection activities?
• How does GCP ensure trial transparency?
• How should clinical trial data be recorded according to GCP?
• What is the purpose of Form FDA 1572?
• What must be submitted to the FDA before conducting a clinical trial for specific devices?
• What is the primary function of an Institutional Review Board (IRB)?
• What is the status of the ICH E6 guidelines in the United States?
• Which entity is responsible for reporting the investigator's financial interests to the FDA?
• What immediate action should be taken for an adverse event that is life-threatening?
• What organization holds the main oversight responsibility for ethical aspects of clinical trials?
• What is the definition of Good Clinical Practice (GCP)?
• What is the goal of obtaining informed consent from study participants?
• How is an Adverse Drug Reaction (ADR) defined before market approval?
• What is required at a prestudy site visit?
• What must an investigator agree to when signing Form FDA 1572?
• What aspect is crucial when determining the causality of an adverse event?
• According to FDA regulations, what type of copy of the informed consent form can subjects receive?
• What is the purpose of monitoring in clinical trials?
• What does "accountability" in clinical trials refer to?
• What is the purpose of providing a statement of conflicts of interest?
• What is the function of a clinical trial master file?
• What could be a consequence of a protocol violation in a clinical trial?
• What must be done if a deviation from the protocol occurs?
• What should be documented when a drug is dispensed to a subject?
• What must an investigator complete when conducting a study under an IDE?
• Why is investigator training necessary in GCP?
• What must sponsors ensure regarding the investigators involved in their studies?
• What must an investigator submit to the sponsor if they are involved in a new protocol?
• What role does the informed consent process play in GCP?
• How often should the consent process be reviewed in clinical trials?
• What is an Unanticipated Adverse Device Effect?
• When should the sponsor-monitor conduct the most detailed review of the study protocol with the site's study staff?